Amgen Inc. buy marge
Start price
21.06.15
/
50%
€141.91
Target price
24.05.16
€160.00
Performance (%)
-3.29%
End price
24.05.16
€134.02
Summary
This prediction ended on 24.05.16 with a price of €134.02. With a performance of -3.29%, the BUY prediction by marge finished with a loss. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Amgen Inc. | 3.004% | 3.004% | 9.523% | 10.065% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% | 68.786% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% | 100.066% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% | 43.024% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% | 63.222% |
Comments by marge for this prediction
In the thread Amgen Inc. diskutieren
Amgen
Aus meinem Langfristportofolio mit den Large-cap biotechs:
1.Gilead Science (40%)
2. Amgen (15%)
3. Celgene (25%),
und den smaller-cap biotechs:
Isis Pharmaceuticals, ChemoCentryx, Acceleron,
Portola Pharmaceuticals, Cempra, Supernus mit anteiliger Gesamtgewichtung von 20%
Nachfragen zu den einzelnen Werten beantworte ich gerne.
(Laufzeit überschritten)